Fluoxetine for the treatment of childhood anxiety disorders
- PMID: 12649628
- DOI: 10.1097/01.CHI.0000037049.04952.9F
Fluoxetine for the treatment of childhood anxiety disorders
Abstract
Objective: To assess the efficacy and tolerability of fluoxetine for the acute treatment of children and adolescents with generalized anxiety disorder, separation anxiety disorder, and/or social phobia.
Method: Anxious youths (7-17 years old) who had significant functional impairment were randomized to fluoxetine (20 mg/day) (n = 37) or placebo (n = 37) for 12 weeks.
Results: Fluoxetine was effective in reducing the anxiety symptoms and improving functioning in all measures. Using intent-to-treat analysis, 61% of patients taking fluoxetine and 35% taking placebo showed much to very much improvement. Despite this improvement, a substantial group of patients remained symptomatic. Fluoxetine was well tolerated except for mild and transient headaches and gastrointestinal side effects. Youths with social phobia and generalized anxiety disorder responded better to fluoxetine than placebo, but only social phobia moderated the clinical and functional response. Severity of the anxiety at intake and positive family history for anxiety predicted poorer functioning at the end of the study.
Conclusions: Fluoxetine is useful and well tolerated for the acute treatment of anxious youths. Investigations regarding the optimization of treatment to obtain full anxiety remission and the length of treatment necessary to prevent recurrences are warranted.
Similar articles
-
Comparison among clomipramine, fluoxetine, and placebo for the treatment of anxiety disorders in children and adolescents.J Child Adolesc Psychopharmacol. 2013 Dec;23(10):687-92. doi: 10.1089/cap.2012.0110. J Child Adolesc Psychopharmacol. 2013. PMID: 24350814 Free PMC article. Clinical Trial.
-
Fluoxetine for the treatment of childhood anxiety disorders: open-label, long-term extension to a controlled trial.J Am Acad Child Adolesc Psychiatry. 2005 Dec;44(12):1263-70. doi: 10.1097/01.chi.0000183464.41777.c1. J Am Acad Child Adolesc Psychiatry. 2005. PMID: 16292118 Clinical Trial.
-
SET-C versus fluoxetine in the treatment of childhood social phobia.J Am Acad Child Adolesc Psychiatry. 2007 Dec;46(12):1622-32. doi: 10.1097/chi.0b013e318154bb57. J Am Acad Child Adolesc Psychiatry. 2007. PMID: 18030084 Clinical Trial.
-
Selective serotonin reuptake inhibitors in the treatment of paediatric anxiety disorders: a review.Int Clin Psychopharmacol. 2000 Aug;15 Suppl 2:S47-63. doi: 10.1097/00004850-200008002-00008. Int Clin Psychopharmacol. 2000. PMID: 11110019 Review.
-
[Efficacy and tolerability of escitalopram in anxiety disorders: a review].Encephale. 2008 Sep;34(4):400-8. doi: 10.1016/j.encep.2008.04.004. Epub 2008 Aug 15. Encephale. 2008. PMID: 18922243 Review. French.
Cited by
-
Comorbid Anxiety and Depressive Symptoms in Children and Adolescents: A Systematic Review and Analysis.J Psychiatr Pract. 2016 Mar;22(2):84-98. doi: 10.1097/PRA.0000000000000132. J Psychiatr Pract. 2016. PMID: 27138077 Free PMC article. Review.
-
Pharmacologic Treatment of Pediatric Anxiety Disorders.Curr Treat Options Psychiatry. 2016 Jun;3(2):151-160. doi: 10.1007/s40501-016-0076-7. Epub 2016 Apr 22. Curr Treat Options Psychiatry. 2016. PMID: 27648401 Free PMC article.
-
Adverse Effects of Antidepressant Medications and their Management in Children and Adolescents.Pharmacotherapy. 2023 Jul;43(7):675-690. doi: 10.1002/phar.2767. Epub 2023 Jan 27. Pharmacotherapy. 2023. PMID: 36651686 Free PMC article. Review.
-
A Sequential Multiple Assignment Randomized Trial (SMART) study of medication and CBT sequencing in the treatment of pediatric anxiety disorders.BMC Psychiatry. 2021 Jun 30;21(1):323. doi: 10.1186/s12888-021-03314-y. BMC Psychiatry. 2021. PMID: 34193105 Free PMC article. Clinical Trial.
-
A preliminary investigation of neural correlates of treatment in adolescents with generalized anxiety disorder.J Child Adolesc Psychopharmacol. 2010 Apr;20(2):105-11. doi: 10.1089/cap.2009.0049. J Child Adolesc Psychopharmacol. 2010. PMID: 20415605 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical